BOSTON, March 22, 2024 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that the company will release its financial results for the fourth quarter and full year ended December 31, 2023 and provide an update on the company on Wednesday, March 27, 2024.
Following the release, management will host a conference call and live webcast at 8:30 AM Eastern Time to discuss the financial results and provide a business update.
Conference Call Dial-In & Webcast Information:
Date/Time: | Wednesday, March 27, 2024 at 8:30 AM Eastern Time |
Domestic: | 1-877-425-9470 |
International: | 1-201-389-0878 |
Conference ID: | 13744446 |
Call me™: | Click here. |
Webcast: | Click here. |
A replay of the webcast will be available on the Company’s website. approximately two hours after the event, for approximately 30 days.
About Gamida Cell
Omisirge® is a registered mark of Gamida Cell Inc. © 2024 Gamida Cell Inc. All Rights Reserved.
Investor Contacts:
Chuck Padala
LifeSci Advisors
chuck@lifesciadvisors.com
1-646-627-8390
